Abstract
Surfactant proteins (SPs) play an important role in surfactant metabolism and function. Understanding their relative contribution to clinical outcome remains incomplete. Exogenous surfactants differ in their SP content and physiologic effects. The aims of this study were to measure bronchoalveolar lavage (BAL) SP concentrations from preterm infants ventilated for respiratory distress syndrome and to assess their association with clinical outcome. Fifty preterm infants randomized to receive a natural or synthetic surfactant were lavaged each day for the first week and twice weekly thereafter using a standardized nonbronchoscopic technique. BAL SP-A, SP-B, and SP-D concentrations were measured using ELISA. Median BAL SP-A, SP-B, and SP-D concentrations for the whole cohort rose significantly during the first postnatal week (p < 0.05). SP-A concentration did not differ between outcome groups. BAL SP-B concentration rose significantly in lungs that were not supplemented with SP-B. Infants dying had significantly lower BAL SP-B concentrations on d 2 and 6 compared with survivors. BAL SP-D concentrations were significantly lower on d 2 and 3 among infants in supplemental oxygen on d 28 compared with those in air. BAL SP-A and SP-D concentrations did not differ significantly between infants randomized to receive a natural or synthetic surfactant. Lower BAL SP-B and SP-D but not SP-A concentrations were associated with worse clinical prognosis.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Abbreviations
- BAL:
-
bronchoalveolar lavage
- CLD:
-
chronic lung disease of prematurity
- IUGR:
-
intrauterine growth retardation
- IVH:
-
intraventricular hemorrhage
- IQR:
-
interquartile range
- NB-BAL:
-
nonbronchoscopic BAL
- RDS:
-
respiratory distress syndrome
- SP:
-
surfactant protein
References
Creuwels LAJM, van Golde LMG, Haagsman HP 1997 The pulmonary surfactant system: biochemical and clinical aspects. Lung 175: 1–39
Davies J, Turner M, Klein N 2001 The role of the collectin system in pulmonary defence. Paediatr Respir Rev 2: 70–75
King RJ, Klass DJ, Gikas EG, Clements JA 1973 Isolation of apoproteins from canine surface active material. Am J Physiol 224: 788–795
Floros J, Kala P 1998 Surfactant proteins: molecular genetics of neonatal pulmonary diseases. Annu Rev Physiol 60: 365–384
Yamada T, Ikegami M, Tabor BL, Jobe AH 1990 Effects of surfactant protein A on surfactant function in preterm ventilated rabbits. Am Rev Respir Dis 142: 754–757
Kuroki Y, Voelker DR 1994 Pulmonary surfactant proteins. J Biol Chem 269: 25943–25946
Hallman M, Merritt TA, Akino T, Bry K 1991 Surfactant protein A, phosphatidylcholine, and surfactant Inhibitors in epithelial lining fluid. Am Rev Respir Dis 144: 1376–1384
Seeger W, Grube C, Gunther A, Schmidt R 1993 Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations. Eur Respir J 6: 971–977
Vaandrager AB, van Golde LMG 2000 Lung surfactant proteins A and D in innate immune defence. Biol Neonate 77( suppl): 9–13
Ikegami M, Whitsett JA, Jobe A, Ross G, Fisher J, Korfhaegn T 2000 Surfactant metabolism in SP-D gene-targeted mice. Am J Physiol Lung Cell Mol Physiol 279: L468–L476
Kala P, Have TT, Nielsen H, Dunn M, Floros J 1998 Association of pulmonary surfactant protein A (SP-A) gene and respiratory distress syndrome: interaction with SP-B. Pediatr Res 43: 169–177
Hamvas A, Nogee LM, deMello DE, Cole FS 1995 Pathophysiology and treatment of surfactant protein-B deficiency. Biol Neonate 67( suppl 1): 18–31
Stevens PA, Schadow B, Bartholain S, Segerer H, Obladen M 1992 Surfactant protein A in the course of respiratory distress syndrome. Eur J Pediatr 151: 596–600
Chida S, Phelps DS, Cordle C, Soll R, Floros J, Taeusch HW 1988 Surfactant-associated proteins in tracheal aspirates of infants with respiratory distress syndrome after surfactant therapy. Am Rev Respir Dis 137: 943–947
Moya FR, Montes HF, Thomas VL, Mouzinho AM, Smith JF, Rosenfeld CR 1994 Surfactant protein A and saturated phosphatidylcholine in respiratory distress syndrome. Am J Respir Crit Care Med 150: 1672–1677
Gerdes J, Whitsett J, Long W 1992 Elastase activity and surfactant protein concentration in tracheal aspirates from neonates receiving synthetic surfactant. J Pediatr 120: S34–S39
Kari MA, Akino T, Hallman M 1995 Prenatal dexamethasone and exogenous surfactant therapy: surface activity and surfactant components in airway specimens. Pediatr Res 38: 676–684
Wang J-Y, Yeh T-F, Lin Y-C, Miyamura K, Holmskov U, Reid KBM 1996 Measurement of pulmonary status and surfactant protein levels during dexamethasone treatment of neonatal respiratory distress syndrome. Thorax 51: 907–913
Gerdes JS, Abbasi S, Karp K, Hull W, Whitsett JA 1990 Surfactant protein-A in bronchoalveolar lavage fluid from neonates with RDS on conventional and high-frequency oscillatory ventilation. Pediatr Pulmonol 9: 166–169
Lotze A, Whitsett JA, Kammerman LA, Ritter M, Taylor GA, Short BL 1990 Surfactant protein A concentrations in tracheal aspirate fluid from infants requiring extracorporeal membrane oxygenation. J Pediatr 116: 435–440
Corcoran JD, Sheehan O, O'Hare MMT, Halliday HL 1995 Tracheal surfactant protein A following treatment with Curosurf. Appl Cardiopulm Pathophysiol 5: 245–248
Rennard SI, Basset G, Lecoossier D, O'Donnell KM, Pinkston P, Martin PG, Crystal RG 1986 Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J Appl Physiol 60: 532–538
Kotecha S 1999 Bronchoalveolar lavage of newborn infants. Pediatr Pulmonol Suppl 18: 122–124
Egberts J, Brand R, Walti H, Bevilacqua C, Bréart G, Gardini F 1997 Mortality, severe respiratory distress syndrome and chronic lung disease of the newborn are reduced more after prophylactic than after therapeutic administration of the surfactant Curosurf. Pediatrics 100: e4
[No authors listed] 1987 Ten centre trial of artificial surfactant (artificial lung expanding compound) in very premature babies. Ten Centre Study Group. BMJ 294: 991–996
Ainsworth SB, Beresford MW, Milligan DWA, Shaw NJ, Matthews JNS, Fenton AC, Ward Platt MP 2000 Pumactant and poractant alfa for treatment of respiratory distress syndrome in neonates born at 25–29 weeks' gestation: a randomised trial. Lancet 355: 1387–1392
Awasthi S, Coalson JJ, Crouch E, Yang F, King RJ 1999 Surfactant proteins A and D in premature baboons with chronic lung injury (bronchopulmonary dysplasia): evidence for an inhibition of secretion. Am J Respir Crit Care Med 160: 942–949
Levene MI 1981 Measurement of the growth of the lateral ventricles in preterm infants with real-time ultrasound. Arch Dis Child 56: 900–904
Papile LA, Burstein J, Burstein R, Koffler H 1978 Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants of birth weight less than 1500 g. J Pediatr 92: 529–534
Kerr M, Paton JY 1999 Surfactant protein levels in severe respiratory syncytial virus infection. Am J Respir Crit Care Med 159: 1115–1118
Wright SM, Hockey PM, Enhorning G, Strong P, Reid KB, Holgate ST, Djukanovic R, Postle AD 2000 Altered airway surfactant phospholipid composition and reduced lung function in asthma. J Appl Physiol 89: 1283–1292
Bland JM, Altman DG 1986 Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1: 307–310
de Blic J, Midulla F, Barbato A, Clement A, Dab I, Eber E, Green C, Grigg J, Kotecha S, Kurland G, Pohunek P, Ratjen F, Rossi G 2000 Bronchoalveolar lavage in children. ERS Task Force on bronchoalveolar lavage in children. European Respiratory Society. Eur Respir J 15: 217–231
Takahashi A, Nemoto T, Fujiwara T 1994 Biophysical properties of protein-free, totally synthetic pulmonary surfactants, ALEC and Exosurf, in comparison with surfactant TA. Acta Paediatr Jpn 36: 613–618
Corcoran JD, Berggren P, Sun B, Halliday HL, Robertson B, Curstedt T 1994 Comparison of surface properties and physiological effects of a synthetic and a natural surfactant in preterm rabbits. Arch Dis Child Fetal Neonatal Ed 71: F165–F169
Chetcuti PJ, Ball RJ 1995 Surfactant apoprotein B deficiency. Arch Dis Child Fetal Neonatal Ed 73: F125–F127
Ikegami M, Korfhagen TR, Whitsett JA, Bruno MD, Wert SE, Wada K, Jobe AH 1998 Characteristics of surfactant from SP-A-deficient mice. Am J Physiol 275: L247–L254
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by The Newborn Appeal, Serono Laboratories, and Britannia Pharmaceuticals.
Rights and permissions
About this article
Cite this article
Beresford, M., Shaw, N. Bronchoalveolar Lavage Surfactant Protein A, B, and D Concentrations in Preterm Infants Ventilated for Respiratory Distress Syndrome Receiving Natural and Synthetic Surfactants. Pediatr Res 53, 663–670 (2003). https://doi.org/10.1203/01.PDR.0000054653.89527.F8
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1203/01.PDR.0000054653.89527.F8
This article is cited by
-
Surfactant protein D and bronchopulmonary dysplasia: a new way to approach an old problem
Respiratory Research (2021)
-
Fetal and neonatal samples of a precursor surfactant protein B inversely related to gestational age
BMC Pediatrics (2013)
-
Spatial and temporal expression of surfactant proteins in hyperoxia-induced neonatal rat lung injury
BMC Pulmonary Medicine (2006)
-
Repeat surfactant therapy for postsurfactant slump
Journal of Perinatology (2006)
